Search
Generic filters
Search in excerpt

An ETF for every investor.

CASH

Horizons High Interest Savings ETF

Price
$50.03
$0.00
0.00%
NAV
$50.0000
$-0.1341
-0.27%

Benchmark

Fixed Income

Fact Sheet
Learn more about CASH

QQCC

Horizons NASDAQ-100 Covered Call ETF

Price
$4.71
$-0.09
-1.88%
NAV
$4.7265
$-0.0990
-2.05%

Active

Covered Call

Fact Sheet
Learn more about QQCC

HRAA

Horizons ReSolve Adaptive Asset Allocation ETF

Price
$11.13
$0.01
0.09%
NAV
$11.1590
$-0.0250
-0.22%

Active

Corporate Class – Alternative

Fact Sheet
Learn more about HRAA
Explore All Products
Search
Generic filters
Search in excerpt
Back to All Products

HVAX

Horizons Global Vaccines and Infectious Diseases Index ETF

Get Exposure to the Companies Leading Vaccine Development

Horizons Global Vaccines and Infectious Diseases Index ETF (HVAX), allows investors to gain exposure to the potentially long-term theme of vaccine development and disease prevention.
 

Key Features

• Provides globally diversified exposure to leading companies that provide research, medicines and vaccines against infectious diseases
• Massive public and private investment during COVID-19 pandemic driving exciting innovation in vaccine and pharmaceutical development
• COVID-19 has likely created a long-term focus on global disease prevention, a potentially long-term trend
• Substantial revenue opportunities from further vaccine and infectious disease development beyond COVID-19

Investment Objective

HVAX seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the development and production of vaccines, therapeutics and diagnostics. Currently, HVAX seeks to replicate, directly or indirectly, the performance of the Solactive Global Vaccines and Infectious Diseases Index, net of expenses. HVAX seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.

Fund Details

Ticker
HVAX
Inception Date
October 26, 2021
Net Assets ?
$1,980,138
As at  September 29, 2022
Consolidated Prior Day Volume ?
6
For  September 29, 2022
Average Daily Trading Volume Over a 12 Month Period ?
468
As at  September 29, 2022
Exchange
Toronto Stock Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
SOCGVAXN
Management Fee
0.60%
(Plus applicable sales tax)
Management Expense Ratio ?
0.71%
As at June 30, 2022
Currency
CAD
Currency Hedging
Seeks to hedge the U.S. dollar value of its portfolio to the Canadian dollar at all times
LEI ?
54930023BO8TOEE8TG37
NAV / Unit
$14.9669
Price
$16.19
Premium Discount
$1.22
Premium Discount Percentage
7.55%
Outstanding Shares
132,301

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Annualized Performance (%) *

Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.

Calendar Year Performance (%) *

Calendar year performance data is not currently available.

Distributions

Distribution data is not currently available.

Sector Allocation

As at August 31, 2022
Health Care 100.00%

Geographic Exposure

As at August 31, 2022
United States 69.10%
France 9.95%
Germany 8.41%
China 7.64%
Britain 3.69%
Australia 1.22%

Top 10 Holdings

As at September 29, 2022
Security Name Weight
Immunitybio Inc 6.06%
Pfizer Inc 5.99%
Vaxcyte Inc 5.89%
BioNTech SE - ADR 5.88%
Merck & Co Inc 5.84%
Maravai LifeSciences Holdings Inc Cl A 5.38%
Moderna Inc 5.26%
Sanofi SA 4.77%
Regeneron Pharmaceuticals Inc 4.71%
Johnson & Johnson 4.59%

Holdings are subject to change. Download full prior business day: Holdings

At a Glance

Get Exposure to the Companies Leading Vaccine Development

Horizons Global Vaccines and Infectious Diseases Index ETF (HVAX), allows investors to gain exposure to the potentially long-term theme of vaccine development and disease prevention.
 

Key Features

• Provides globally diversified exposure to leading companies that provide research, medicines and vaccines against infectious diseases
• Massive public and private investment during COVID-19 pandemic driving exciting innovation in vaccine and pharmaceutical development
• COVID-19 has likely created a long-term focus on global disease prevention, a potentially long-term trend
• Substantial revenue opportunities from further vaccine and infectious disease development beyond COVID-19

Product Facts

Investment Objective

HVAX seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the development and production of vaccines, therapeutics and diagnostics. Currently, HVAX seeks to replicate, directly or indirectly, the performance of the Solactive Global Vaccines and Infectious Diseases Index, net of expenses. HVAX seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.

Fund Details

Ticker
HVAX
Inception Date
October 26, 2021
Net Assets ?
$1,980,138
As at September 29, 2022
Consolidated Prior Day Volume ?
6
For September 29, 2022
Average Daily Trading Volume Over a 12 Month Period ?
468
As at September 29, 2022
Exchange
Toronto Stock Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
SOCGVAXN
Management Fee
0.60%
(Plus applicable sales tax)
Management Expense Ratio ?
0.71%
 As at June 30, 2022
Currency
CAD
Currency Hedging
Seeks to hedge the U.S. dollar value of its portfolio to the Canadian dollar at all times
LEI ?
54930023BO8TOEE8TG37
NAV / Unit
$14.9669
Price
$16.19
Premium Discount
$1.22
Premium Discount Percentage
7.55%
Outstanding Shares
132,301

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Performance & Distributions

Annualized Performance (%)

Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.

Calendar Year Performance (%)

Calendar year performance data is not currently available.

Distributions

Distribution data is not currently available.

Holdings

Sector Allocation

As at August 31, 2022
Health Care 100.00%

Geographic Exposure

As at  August 31, 2022
United States 69.10%
France 9.95%
Germany 8.41%
China 7.64%
Britain 3.69%
Australia 1.22%

Top 10 Holdings

As at September 29, 2022
Security Name Weight
Immunitybio Inc 6.06%
Pfizer Inc 5.99%
Vaxcyte Inc 5.89%
BioNTech SE - ADR 5.88%
Merck & Co Inc 5.84%
Maravai LifeSciences Holdings Inc Cl A 5.38%
Moderna Inc 5.26%
Sanofi SA 4.77%
Regeneron Pharmaceuticals Inc 4.71%
Johnson & Johnson 4.59%

Holdings are subject to change. Download full prior business day: Holdings

Related Posts

At Horizons ETFs, we believe in education as empowerment. We endeavor to equip Canadian investors with the knowledge and tools they need to navigate the investing world. From the ETF basics to more complex topics like how our suite of inverse and leveraged funds work, our comprehensive learning library aims to be accessible for all investors, from beginners to experienced traders!